On January 7, 2025, Ping An Health Medical Technology Company (PA GOODDOCTOR) announced a trade disclosure. According to Rule 22 of the Hong Kong Code on Takeovers and Mergers, executives received a disclosure regarding a securities transaction conducted by Morgan Stanley & Co., International plc on January 6, 2025.The transaction involved ordinary shares of PA GOODDOCTOR and pertains to hedging activities generated by Delta 1 products resulting from active buy and sell orders initiated by clients and driven by client demand. Specific transactions include: buying 10,000 shares for a total amount of HKD 62,500, with a per-share price between HKD 6.24 and HKD 6.27; selling 13,700 shares for a total amount of HKD 86,367, with a per-share price between HKD 6.25 and HKD 6.32.This trade disclosure is related to a potential mandatory general offer, indicating active trading of PA GOODDOCTOR shares in the market. Investors should closely monitor subsequent developments and any progress regarding the potential offer.

On January 7, 2025, Ping An Health Medical Technology Company (PA GOODDOCTOR) announced a trade disclosure. According to Rule 22 of the Hong Kong Code on Takeovers and Mergers, executives received a disclosure regarding a securities transaction conducted by Morgan Stanley & Co., International plc on January 6, 2025.The transaction involved ordinary shares of PA GOODDOCTOR and pertains to hedging activities generated by Delta 1 products resulting from active buy and sell orders initiated by clients and driven by client demand. Specific transactions include: buying 10,000 shares for a total amount of HKD 62,500, with a per-share price between HKD 6.24 and HKD 6.27; selling 13,700 shares for a total amount of HKD 86,367, with a per-share price between HKD 6.25 and HKD 6.32.This trade disclosure is related to a potential mandatory general offer, indicating active trading of PA GOODDOCTOR shares in the market. Investors should closely monitor subsequent developments and any progress regarding the potential offer.